var eventsData = [{"Ticker":"CFN","EffectiveDate":"2014-10-22","Type":"RatingNeutral","Title":"Raymond James downgrades CFN to Market Perform from Strong Buy; previously $52.","DailyReturn":"0.03%","FiveDayReturnAfter":"1.1%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"CFN","EffectiveDate":"2014-10-07","Type":"RatingNeutral","Title":"JP Morgan downgrades CFN to Neutral from Overweight. Target Price is $59; previously $48.","DailyReturn":"0.52%","FiveDayReturnAfter":"0.35%","FiveDayReturnBefore":"21.43%"},{"Ticker":"CFN","EffectiveDate":"2014-10-06","Type":"RatingNeutral","Title":"PiperJaffray downgrades CFN to Neutral from Overweight. Target Price is $48; previously $38.","DailyReturn":"22.91%","FiveDayReturnAfter":"21.45%","FiveDayReturnBefore":"0.93%"},{"Ticker":"CFN","EffectiveDate":"2014-08-15","Type":"RatingNeutral","Title":"Raymond James maintains CFN to Strong Buy. Target Price is $52; previously $50.","DailyReturn":"-0.15%","FiveDayReturnAfter":"2.26%","FiveDayReturnBefore":"4.48%"},{"Ticker":"CFN","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CFN to Buy. Target Price is $49; previously $42.","DailyReturn":"0.9%","FiveDayReturnAfter":"4.48%","FiveDayReturnBefore":"-3.91%"},{"Ticker":"CFN","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"JP Morgan maintains CFN to Overweight. Target Price is $48; previously $44.","DailyReturn":"0.9%","FiveDayReturnAfter":"4.48%","FiveDayReturnBefore":"-3.91%"},{"Ticker":"CFN","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"BMO Capital maintains CFN to Outperform. Target Price is $48; previously $46.","DailyReturn":"0.9%","FiveDayReturnAfter":"4.48%","FiveDayReturnBefore":"-3.91%"},{"Ticker":"CFN","EffectiveDate":"2014-05-19","Type":"RatingNeutral","Title":"Raymond James maintains CFN to Strong Buy. Target Price is $50; previously $48.","DailyReturn":"0.93%","FiveDayReturnAfter":"-1.19%","FiveDayReturnBefore":"4.2%"},{"Ticker":"CFN","EffectiveDate":"2014-05-06","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CFN to Neutral from Sell. Target Price is $40; previously $37.","DailyReturn":"-0.15%","FiveDayReturnAfter":"4.58%","FiveDayReturnBefore":"1.71%"},{"Ticker":"CFN","EffectiveDate":"2014-05-06","Type":"RatingNeutral","Title":"Barclays maintains CFN to Equal-Weight. Target Price is $42; previously $44.","DailyReturn":"-0.15%","FiveDayReturnAfter":"4.58%","FiveDayReturnBefore":"1.71%"},{"Ticker":"CFN","EffectiveDate":"2013-12-18","Type":"RatingNeutral","Title":"Bank of America maintains CFN to Buy. Target Price is $45; previously $43.","DailyReturn":"2.65%","FiveDayReturnAfter":"3.34%","FiveDayReturnBefore":"-2.51%"},{"Ticker":"CFN","EffectiveDate":"2013-12-17","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CFN to Sell from Neutral. Target Price is $36; previously $35.","DailyReturn":"-2.53%","FiveDayReturnAfter":"0.1%","FiveDayReturnBefore":"-1.88%"},{"Ticker":"CFN","EffectiveDate":"2013-11-07","Type":"EarningsRevenueBeat","Title":"After market close, CFN reports 2014 Q1's earning $0.44 per share and revenue $830MM. This beats analyst's estimated EPS $0.39, beats estimated revenue $818.69MM.","DailyReturn":"-0.98%","FiveDayReturnAfter":"1%","FiveDayReturnBefore":"-0.56%"},{"Ticker":"CFN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CFN to Buy. Target Price is $42; previously $37.","DailyReturn":"-0.99%","FiveDayReturnAfter":"-3.12%","FiveDayReturnBefore":"-4.27%"},{"Ticker":"CFN","EffectiveDate":"2013-08-08","Type":"EarningsRevenueMiss","Title":"After market close, CFN reports 2013 Q4's earning $0.55 per share and revenue $903MM. This misses analyst's estimated EPS $0.56, misses estimated revenue $918.25MM.","DailyReturn":"1.11%","FiveDayReturnAfter":"1.45%","FiveDayReturnBefore":"-4.39%"},{"Ticker":"CFN","EffectiveDate":"2013-07-12","Type":"RatingNeutral","Title":"JP Morgan maintains CFN to Overweight. Target Price is $41; previously $35.","DailyReturn":"0.1%","FiveDayReturnAfter":"0.77%","FiveDayReturnBefore":"2.97%"},{"Ticker":"CFN","EffectiveDate":"2013-07-08","Type":"RatingNeutral","Title":"BMO Capital maintains CFN to Outperform. Target Price is $42; previously $48.","DailyReturn":"1.75%","FiveDayReturnAfter":"2.57%","FiveDayReturnBefore":"1.96%"},{"Ticker":"CFN","EffectiveDate":"2013-05-09","Type":"EarningsBeatRevenueMiss","Title":"After market close, CFN reports 2013 Q3's earning $0.59 per share and revenue $901MM. This beats analyst's estimated EPS $0.53, misses estimated revenue $907.8MM.","DailyReturn":"0.08%","FiveDayReturnAfter":"-2.69%","FiveDayReturnBefore":"4.15%"},{"Ticker":"CFN","EffectiveDate":"2013-04-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains CFN to Hold. Target Price is $35; previously $34.","DailyReturn":"-0.28%","FiveDayReturnAfter":"-3.42%","FiveDayReturnBefore":"1.73%"},{"Ticker":"CFN","EffectiveDate":"2013-02-20","Type":"RatingNeutral","Title":"Barclays maintains CFN to Equal-Weight. Target Price is $36; previously $32.","DailyReturn":"-1.08%","FiveDayReturnAfter":"-3%","FiveDayReturnBefore":"1.95%"},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CFN to Buy. Target Price is $37; previously $33.","DailyReturn":"0.06%","FiveDayReturnAfter":"2.81%","FiveDayReturnBefore":"2.51%"},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Barclays maintains CFN to Equal-Weight. Target Price is $32; previously $28.","DailyReturn":"0.06%","FiveDayReturnAfter":"2.81%","FiveDayReturnBefore":"2.51%"},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Credit Agricole downgrades CFN to Outperform from Buy. Target Price is $36; previously $30.","DailyReturn":"0.06%","FiveDayReturnAfter":"2.81%","FiveDayReturnBefore":"2.51%"},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"BMO Capital maintains CFN to Outperform. Target Price is $35; previously $34.","DailyReturn":"0.06%","FiveDayReturnAfter":"2.81%","FiveDayReturnBefore":"2.51%"},{"Ticker":"CFN","EffectiveDate":"2013-02-07","Type":"EarningsRevenueBeat","Title":"After market close, CFN reports 2013 Q2's earning $0.54 per share and revenue $909MM. This beats analyst's estimated EPS $0.44, beats estimated revenue $908.4MM.","DailyReturn":"1.24%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"0.92%"},{"Ticker":"CFN","EffectiveDate":"2013-01-18","Type":"RatingNeutral","Title":"UBS maintains CFN to Buy. Target Price is $34; previously $32.","DailyReturn":"0.91%","FiveDayReturnAfter":"0.98%","FiveDayReturnBefore":"2.62%"},{"Ticker":"CFN","EffectiveDate":"2013-01-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains CFN to Hold. Target Price is $32; previously $28.","DailyReturn":"0.03%","FiveDayReturnAfter":"1.9%","FiveDayReturnBefore":"2.04%"},{"Ticker":"CFN","EffectiveDate":"2013-01-03","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CFN to Equal-Weight from Overweight.","DailyReturn":"-0.64%","FiveDayReturnAfter":"0.64%","FiveDayReturnBefore":"2.73%"},{"Ticker":"CFN","EffectiveDate":"2012-12-13","Type":"RatingNeutral","Title":"UBS maintains CFN to Buy. Target Price is $32; previously $30.","DailyReturn":"-0.21%","FiveDayReturnAfter":"0.88%","FiveDayReturnBefore":"1.96%"},{"Ticker":"CFN","EffectiveDate":"2012-11-20","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on CFN to Buy. Target Price is $33.","DailyReturn":"1.06%","FiveDayReturnAfter":"2.39%","FiveDayReturnBefore":"0.66%"},{"Ticker":"CFN","EffectiveDate":"2012-11-08","Type":"EarningsRelease","Title":"After market close, CFN reports 2013 Q1's earning $0.37 per share and revenue $837MM..","DailyReturn":"-0.26%","FiveDayReturnAfter":"-0.59%","FiveDayReturnBefore":"1.23%"},{"Ticker":"CFN","EffectiveDate":"2012-09-10","Type":"RatingNeutral","Title":"Goldman Sachs maintains CFN to Neutral. Target Price is $28; previously $27.","DailyReturn":"-0.21%","FiveDayReturnAfter":"0.39%","FiveDayReturnBefore":"5.48%"},{"Ticker":"CFN","EffectiveDate":"2012-09-06","Type":"RatingNeutral","Title":"UBS maintains CFN to Buy. Target Price is $30; previously $29.","DailyReturn":"1.2%","FiveDayReturnAfter":"4.39%","FiveDayReturnBefore":"0%"},{"Ticker":"CFN","EffectiveDate":"2012-08-10","Type":"RatingNeutral","Title":"Citigroup maintains CFN to Buy. Target Price is $30; previously $28.","DailyReturn":"7%","FiveDayReturnAfter":"9.06%","FiveDayReturnBefore":"2.3%"},{"Ticker":"CFN","EffectiveDate":"2012-08-09","Type":"EarningsRevenueBeat","Title":"CFN reports 2012 Q4's earning $0.51 per share and revenue $968MM. This beats analyst's estimated EPS $0.5, beats estimated revenue $959.95MM.","DailyReturn":"0.69%","FiveDayReturnAfter":"9.34%","FiveDayReturnBefore":"-0.04%"},{"Ticker":"CFN","EffectiveDate":"2012-05-09","Type":"EarningsRelease","Title":"After market close, CFN reports 2012 Q3's earning $0.14 per share and revenue $919MM..","DailyReturn":"-1.7%","FiveDayReturnAfter":"-4.49%","FiveDayReturnBefore":"1.41%"},{"Ticker":"CFN","EffectiveDate":"2012-02-21","Type":"RatingNeutral","Title":"Scotiabank maintains CFN to Sector Outperform. Target Price is $215; previously $190.","DailyReturn":"0.15%","FiveDayReturnAfter":"-1.08%","FiveDayReturnBefore":"2.25%"},{"Ticker":"CFN","EffectiveDate":"2012-02-17","Type":"RatingUpgrade","Title":"Morgan Keegan upgrades CFN to Outperform from Market Perform. Target Price is $31; previously $26.","DailyReturn":"0.73%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"4.14%"}];